National
Obama kicks off 2012 re-election campaign
Some LGBT advances, but other ’08 promises unfulfilled
President Obama (Blade photo by Michael Key)
President Obama kicked off his re-election campaign this week as LGBT advocates urged supporters to continue backing him as the 2012 election approaches.
On Monday, Obama filed papers with the Federal Election Commission indicating that he would run for re-election and sent a letter to supporters via his campaign to pump them up for election season.
“We’re doing this now because the politics we believe in does not start with expensive TV ads or extravaganzas, but with you — with people organizing block-by-block, talking to neighbors, co-workers, and friends,” Obama wrote. “And that kind of campaign takes time to build.”
“So even though I’m focused on the job you elected me to do, and the race may not reach full speed for a year or more, the work of laying the foundation for our campaign must start today,” Obama continued.
Obama seems unlikely to face a serious challenger in the Democratic primaries. With his approval ratings rising to about 53 percent, according an Associated Press poll published last week, the president also heads into election season as a strong candidate against any Republican opponent in the general election.
Media outlets have speculated that Obama’s campaign could be the first in history that will raise $1 billion to propel a U.S. presidential candidate to the White House. As in 2008, Obama is expected to run strictly on donations from supporters and not to accept federal public financing.
Obama supporters noted the accomplishments he’s made for the LGBT community during his first term in office.
One of the steps the president has unilaterally taken is mandating hospitals that receive funding under Medicare and Medicaid offer visitation rights for same-sex couples and adding gender identity as a category of non-discrimination for federal workers. Under his administration, Congress also passed a hate crimes law inclusive of sexual orientation and gender identity and legislation allowing for repeal of “Don’t Ask, Don’t Tell.”
Still, some campaign promises that Obama made to the LGBT community in 2008 remain unfulfilled. For example, Congress has yet to pass an Employment Non-Discrimination Act with protections based on both sexual orientation and gender identity and the Defense of Marriage Act, which Obama supported repealing it its entirety, still remains on the books.
Jamie Citron, director of the Democratic National Committee’s LGBT Leadership Council, said Obama’s accomplishments during his first term demonstrate why LGBT people should continue their support — and why many are already gearing up for the new campaign.
“I think that the president over the few years — especially looking at the some of the accomplishments — has made it very, very clear that he has the community’s back and that we are at the heart of his vision for this country moving forward,” Citron said.
Among the acts that Citron cited were making a record number of openly LGBT appointments, declaring DOMA to be unconstitutional and directing the Justice Department to no longer defend the law in court and taking on anti-bullying efforts that included holding a conference against student harassment at the White House.
“I think this adds up to a very clear stance on the part of the president that he has the LGBT community in mind,” Citron said. “It’s not the type of thing that the president does to be showy or to gain support; it’s because he believes it’s the right thing to do, and I think that’s important.”
As he maintained that Obama has acted on behalf on the LGBT community, Citron said that LGBT support is needed for the president as he heads into campaign season. Citron said the coalition that worked to elect Obama in 2008 needs to expand for success in 2012.
“The LGBT community is one that over the last few years has found its footing its incredible ways, has found its voice and has really — here in Washington and all over the country — made sure its voice is heard,” Citron said. “We’re going to need that type of energy and voice to make sure the accomplishments that I was just talking about are out there and LGBT Americans all across the country — in big towns and small — know about them as well.”
Many LGBT advocates are similarly urging continued backing of Obama in his re-election campaign.
Fred Sainz, vice president of communications for the Human Rights Campaign, reiterated Obama’s accomplishments for the LGBT community during his first term in office.
“President Obama has been a steadfast advocate for LGBT families and the issues that are important to them,” Sainz said. “From the passage of the hate crimes protection act to the repeal of ‘Don’t Ask, Don’t Tell,’ and countless other decisions to further equality, this president has made better the lives of millions in our community.”
Sainz noted HRC has not yet endorsed any presidential candidate for the 2012 election.
Michael Mitchell, executive director of the National Stonewall Democrats, similarly advocated for the president and touted the achievements that he has made thus far.
“Barack Obama was the right choice for America in 2008 and is still very much the right choice for America in 2012,” Mitchell said. “Because of the scores of actions beneficial to the LGBT community that the Obama administration has taken — all of which would have never happened under a GOP administration — President Obama is also the right choice for the LGBT community.”
But John Aravosis, the gay editor of AMERICAblog, said LGBT people should see more from Obama during his first term as they recommit to his re-election in 2012.
“We’re still a good year and a half until the presidential elections, but if the president continues along his current path — and finishes repealing ‘Don’t Ask, Don’t Tell,’ signs an executive order on ENDA, and comes out in favor of marriage equality — I think the community could and should vigorously support his re-election,” Aravosis said. “He has ample time to show us that his recent renewed interest in our civil rights is sincere and sustained.”
The Republican National Committee has already capitalized on Obama’s support for the LGBT community in an attack on the president on the committee’s website that was launched on the day Obama announced he would pursue re-election.
Acts in support of the LGBT community are listed among the 10 things the RNC cites as “The Case Against Obama: Social Issues” on its “Hope Isn’t Hiring” page.
The LGBT-related items are “Despite It Being the Law of the Land, Obama Refused to Continue Defending the Defense of Marriage Act in Court,” “Obama Repealed ‘Don’t Ask, Don’t Tell’ While U.S. Troops Are Still on the Battlefield” and “Obama Opposed California’s Prop 8 and Has Expanded Government Recognition of Same-Sex Couples.”
In a letter dated April 5, Joe Solmonese, president of the Human Rights Campaign, wrote to Republican National Committee Chairman Reince Priebus to question why the Republican Party would attack Obama for acts that benefited the LGBT community.
“From the way in which certain issues are detailed, reasonable people would conclude that the RNC believes in discrimination against LGBT people,” Solmonese writes. “You sensationalize issues like hospital visitation rights for loving families and ending housing discrimination when the truth is Americans agree that these are the right things to do.”
The RNC didn’t immediately respond to the Washington Blade’s request for comment on the HRC letter.
R. Clarke Cooper, executive director of Log Cabin Republicans, said his organization has spoken with the RNC about the anti-LGBT initiative and expressed disapproval.
“We are in communication with the RNC on this issue and have made it clear that this kind of divisive rhetoric is not what Americans voted for in 2010 and will hurt, rather than help Republicans in 2012,” Cooper said. “The RNC’s message that hope isn’t hiring is strong enough as an indictment of the Obama administration’s failures on leadership and the economy. There is no need to weaken that message by raising social issues in ways that turn off the average voter.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
Advocates say MTG bill threatens trans youth, families, and doctors
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Far-right José Antonio Kast elected Chile’s next president
Lighting candles in a time of exhaustion
In real estate, trust the process
-
Politics2 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia2 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Chile5 days ago
Far-right José Antonio Kast elected Chile’s next president
-
Opinions3 days ago
Lighting candles in a time of exhaustion
